Forbes June 20, 2024
Arianna Johnson

Topline

Several medical spas and wellness centers are facing potential lawsuits from drugmaker Eli Lilly for allegedly selling compounded and counterfeit versions of ultra-popular weight loss and diabetes drugs Mounjaro and Zepbound, a problem also raised by Ozempic maker Novo Nordisk—and health organizations warn these products may pose serious side effects like infections.

Key Facts

How To Tell If Your Weight Loss Drugs Are Fake

There are several ways to spot fake GLP-1 drugs. Lilly noted some fake versions of its products have a pink hue instead of being colorless like the official products. If the product is labeled as generic tirzepatide or semaglutide then it’s fake because neither Lilly nor Novo Nordisk sells generic versions of its drugs. Another...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Pharma Pulse 12/12/24: Coverage from Trade & Channel Strategies 2024, ASHP Midyear & more
The Impact of the Presidential Election on Pharma: Q&A with Arthur Wong
AbbVie Completes Acquisition of Aliada Therapeutics
The IRA And Post-Approval Clinical Research For Cancer Medicines
Proteomics and AI unite for a new era in medicine and health care

Share This Article